BlackRock Inc. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$148,082,667
-56.8%
15,803,913
+13.1%
0.00%
-55.6%
Q2 2023$342,805,698
+5.6%
13,974,957
+0.1%
0.01%
-10.0%
Q1 2023$324,744,275
-9.2%
13,955,491
-1.3%
0.01%
-9.1%
Q4 2022$357,798,054
+33.8%
14,136,628
+1.9%
0.01%
+22.2%
Q3 2022$267,486,000
-18.0%
13,873,726
+8.3%
0.01%
-10.0%
Q2 2022$326,313,000
+135.1%
12,811,690
+137.4%
0.01%
+150.0%
Q1 2022$138,790,000
-37.6%
5,396,184
+1.7%
0.00%
-33.3%
Q4 2021$222,248,000
-1.0%
5,308,049
+2.9%
0.01%0.0%
Q3 2021$224,548,000
-4.7%
5,159,629
+3.6%
0.01%
-14.3%
Q2 2021$235,531,000
-13.1%
4,981,638
-5.7%
0.01%
-12.5%
Q1 2021$270,984,000
+85.7%
5,285,440
-3.0%
0.01%
+60.0%
Q4 2020$145,911,000
+4.3%
5,448,477
+33.7%
0.01%0.0%
Q3 2020$139,865,000
-11.6%
4,074,161
+5.5%
0.01%
-16.7%
Q2 2020$158,215,000
+940.3%
3,861,689
+770.1%
0.01%
+500.0%
Q1 2020$15,209,000
+336.4%
443,818
+60.2%
0.00%
Q4 2019$3,485,000277,0490.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders